ClinicalTrials.gg
Sign In

Muscular Diseases clinical trials

The registry lists 232 studies for Muscular Diseases across more than 10 countries. 54 are recruiting or about to start. 98 of them are mainly about Muscular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 43 narrower conditions too, such as Fibromyalgia: 6,992 studies, 1,563 open.

Get an email when these change. Save the Muscular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
114
Recruiting
38
Status unknown
31
Terminated
15
Active, not recruiting
9
Withdrawn
8

Phase

Phase 2
33
Phase 1
24
Phase 3
21
Phase 4
10

Where

United States
99
France
35
Canada
28
Germany
28
United Kingdom
28
Spain
24

Who runs them

National Institute of Neurological Disorders and Stroke (NINDS) (7) · Novartis Pharmaceuticals (5) · Assiut University (4) · Beth Israel Deaconess Medical Center (4) · University of Sao Paulo (4) · Vanderbilt University Medical Center (4) · Institut de Myologie, France (3) · Vanderbilt University (3)

What is being tested here

Drugs under test in Muscular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tributyrin101
Delpacibart zotadirsen111
Anitocabtagene autoleucel101
Napazimone101
Ataluren033
Atorvastatin003
Deramiocel012
KZR-616002
Cyclobenzaprine022
Andecaliximab011

Drug classes tested here Statins 4

Coming up

7phase 3 studies under way
14studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 38 Muscular Diseases studies recruiting now, 21 (55%) set no upper age limit and 10 (26%) stop at 75 or younger. 15 (39%) take children under 18. 0 (0%) are for women only and 1 (3%) for men only; 8 (21%) take healthy volunteers.

Recruiting studies that take each age, of 38
AgeWomenMen
1012 (32%)13 (34%)
1836 (95%)36 (95%)
3035 (92%)35 (92%)
4036 (95%)36 (95%)
5036 (95%)36 (95%)
6536 (95%)36 (95%)
7533 (87%)33 (87%)
8525 (66%)25 (66%)

Across all 232 studies, recruiting or not: 32% stop at 75 or younger and 21% at 65; 34% take children; 2% are for women only and 10% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Muscular Diseases studies take

Of 42 interventional studies with no phase under Muscular Diseases, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase18 mo4–40 · 42 studies—18 mo4–40 · 41 studies
Observational75 mo20–159 · 36 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 232. Browse all 232 → or search them.